Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (21-30 of 401) with videos related to

Pageof 41
Sort By:
Interventional Cardiology Clinics|November 26, 2016
Ticagrelor: Effects Beyond the P2Y<sub>12</sub> ReceptorWael Sumaya, Robert F Storey
Journal of Cardiovascular Translational Research|December 7, 2013
Impact of aspirin dosing on the effects of P2Y12 inhibition in patients with acute coronary syndromesMark R Thomas, Robert F Storey
Vascular Pharmacology|June 9, 2016
Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitorsMark R Thomas, Robert F Storey
Platelets|June 5, 2015
The future of P2Y12 receptor antagonistsMark R Thomas, Robert F Storey
Thrombosis and Haemostasis|July 10, 2015
Effect of P2Y12 inhibitors on inflammation and immunityMark R Thomas, Robert F Storey
Thrombosis and Haemostasis|August 22, 2015
The role of platelets in inflammationMark R Thomas, Robert F Storey
Heart (British Cardiac Society)|October 31, 2020
Antithrombotic therapy for patients with chronic coronary syndromesWilliam Ae Parker, Robert F Storey
Current Treatment Options in Cardiovascular Medicine|December 21, 2011
Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary interventionMark R Thomas, Robert F Storey
Progress in Molecular Biology and Translational Science|April 23, 2014
Genetics of response to antiplatelet therapyMark R Thomas, Robert F Storey
Lancet (London, England)|December 17, 2009
The right oral antithrombotics in acute coronary syndromesErik L Grove, Robert F Storey
Pageof 41

Showing results (21-30 of 401) with videos related to

Sort By:
Pageof 41
Interventional Cardiology Clinics|November 26, 2016
Ticagrelor: Effects Beyond the P2Y<sub>12</sub> ReceptorWael Sumaya, Robert F Storey
Journal of Cardiovascular Translational Research|December 7, 2013
Impact of aspirin dosing on the effects of P2Y12 inhibition in patients with acute coronary syndromesMark R Thomas, Robert F Storey
Vascular Pharmacology|June 9, 2016
Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitorsMark R Thomas, Robert F Storey
Platelets|June 5, 2015
The future of P2Y12 receptor antagonistsMark R Thomas, Robert F Storey
Thrombosis and Haemostasis|July 10, 2015
Effect of P2Y12 inhibitors on inflammation and immunityMark R Thomas, Robert F Storey
Thrombosis and Haemostasis|August 22, 2015
The role of platelets in inflammationMark R Thomas, Robert F Storey
Heart (British Cardiac Society)|October 31, 2020
Antithrombotic therapy for patients with chronic coronary syndromesWilliam Ae Parker, Robert F Storey
Current Treatment Options in Cardiovascular Medicine|December 21, 2011
Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary interventionMark R Thomas, Robert F Storey
Progress in Molecular Biology and Translational Science|April 23, 2014
Genetics of response to antiplatelet therapyMark R Thomas, Robert F Storey
Lancet (London, England)|December 17, 2009
The right oral antithrombotics in acute coronary syndromesErik L Grove, Robert F Storey
Pageof 41